Korro Bio (KRRO) shares rose 13.5% in recent Thursday trading after Piper Sandler upgraded the stock to overweight from neutral and raised its price target to $30 per share from $11.
HC Wainwright and Chardan also upgraded the stock to buy from neutral. HC Wainwright had a price target of $20 per share, while Chardan boosted its price target to $15 per share from $7.
Trading volume stood at about 970,500 shares compared with a daily average of 533,201.
Price: 13.31, Change: +1.62, Percent Change: +13.82